Results 241 to 250 of about 7,902,273 (364)
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Cross-regional dynamics of antibiotic resistance (AR): Genomic evidence of transmission for <i>Escherichia coli</i> carrying last-resort AR gene between food animals and humans in China. [PDF]
Hou J +6 more
europepmc +1 more source
Review of Fellow Creatures: Our Obligations to the Other Animals
A. G. Holdier
openalex +1 more source
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
Associations Between Adoption Discounts, Length-of-Stay, and Adoption Rates of Dogs in an Open-Admission Municipal Animal Shelter in NSW, Australia. [PDF]
Qiu T, Maher SJ, Hall E, Westman ME.
europepmc +1 more source
Thangam Ravindranathan et Antoine Traisnel, Donner le change. L’impensé animal.
Claire Cazajous-Augé
doaj

